scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0006-3223(99)00243-7 |
P698 | PubMed publication ID | 10686268 |
P2093 | author name string | Charney DS | |
Berman RM | |||
Hoffman RE | |||
Boutros NN | |||
Hu XS | |||
Miano AP | |||
Sanacora G | |||
Narasimhan M | |||
P2860 | cites work | An Inventory for Measuring Depression | Q26778503 |
The assessment of anxiety states by rating | Q29614719 | ||
Transcranial magnetic stimulation: applications in neuropsychiatry | Q30572921 | ||
Functional neuroimaging studies of depression: the anatomy of melancholia | Q32089512 | ||
Limbic-cortical dysregulation: a proposed model of depression | Q41581021 | ||
Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression | Q48192263 | ||
Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study | Q48240509 | ||
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial | Q48587129 | ||
Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. | Q48960526 | ||
Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. | Q51192900 | ||
Resistance to antidepressant medications and short-term clinical response to ECT | Q58958047 | ||
Transient Depressive Relapse Induced by Catecholamine Depletion | Q59792493 | ||
Reliability and validity of the symptoms of major depressive illness | Q70042161 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 332-337 | |
P577 | publication date | 2000-02-01 | |
P1433 | published in | Biological Psychiatry | Q4914961 |
P1476 | title | A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. | |
P478 | volume | 47 |
Q37468564 | "Getting physical": the management of neuropsychiatric disorders using novel physical treatments |
Q57258434 | A controlled trial of daily left prefrontal cortex TMS for treating depression |
Q48056935 | A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [13C6]-labeled b |
Q36532947 | A novel coil array for combined TMS/fMRI experiments at 3 T |
Q44315065 | A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression |
Q48830665 | A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression |
Q45101123 | A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression. |
Q36946037 | A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression |
Q59138125 | Accelerated rTMS: A Potential Treatment to Alleviate Refractory Depression |
Q30797011 | Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data |
Q36237800 | An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease |
Q34110888 | Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS). |
Q34591323 | Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis |
Q64063350 | Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis |
Q30654701 | Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review |
Q34172513 | Blinding success of rTMS applied to the dorsolateral prefrontal cortex in randomised sham-controlled trials: a systematic review |
Q55264939 | Changing Brain Networks Through Non-invasive Neuromodulation. |
Q44235501 | Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. |
Q46622139 | Clinical application of single-pulse transcranial magnetic stimulation for the treatment of depression |
Q37971293 | Depression in Parkinson disease--epidemiology, mechanisms and management. |
Q37101257 | Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression |
Q37686914 | Does rTMS alter neurocognitive functioning in patients with panic disorder/agoraphobia? An fNIRS-based investigation of prefrontal activation during a cognitive task and its modulation via sham-controlled rTMS |
Q35126273 | Does transcranial direct current stimulation to prefrontal cortex affect mood and emotional memory retrieval in healthy individuals? |
Q44466172 | Duration of transcranial magnetic stimulation effects on the neuroendocrine stress response and coping behavior of adult male rats |
Q30470391 | ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review |
Q42167257 | Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study |
Q60633429 | Efficacité de la stimulation magnétique transcrânienne (rTMS) dans le traitement de la dépression : revue de la littérature |
Q30500173 | Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis |
Q35067542 | Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders |
Q35140368 | Efficacy of repetitive transcranial magnetic stimulation in depression: a review of the evidence |
Q43248389 | HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging |
Q35048171 | Is it time to introduce repetitive transcranial magnetic stimulation into standard clinical practice for the treatment of depressive disorders? |
Q41449605 | Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders? |
Q48398082 | Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression |
Q51972399 | Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. |
Q44375860 | Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy |
Q44123501 | Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers |
Q55365522 | Less Might Be More: Conduction Failure as a Factor Possibly Limiting the Efficacy of Higher Frequencies in rTMS Protocols. |
Q48066114 | Longer depressive episode duration negatively influences HF-rTMS treatment response: a cerebellar metabolic deficiency? |
Q48036786 | Low Potential of Basimglurant to Be Involved in Drug-Drug Interactions: Influence of Non-Michaelis-Menten P450 Kinetics on Fraction Metabolized. |
Q38968671 | MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder |
Q35583587 | Meta-Review of Metanalytic Studies with Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depression |
Q53283065 | Meta-analysis of the Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. |
Q33604899 | More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997-2013 |
Q27319996 | Neural substrates for the motivational regulation of motor recovery after spinal-cord injury |
Q37634301 | Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. |
Q34656273 | Neurostimulation therapies in depression: a review of new modalities |
Q35236721 | Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities |
Q34778249 | Novel physical treatments for the management of neuropsychiatric disorders |
Q35608399 | Prefrontal cortex stimulation as antidepressant treatment: mode of action and clinical effectiveness of rTMS. |
Q35608375 | Pulse configuration and rTMS efficacy: a review of clinical studies. |
Q28364782 | Recent advances: Psychiatry |
Q36368849 | Recent developments and current controversies in depression |
Q98947202 | Reconfigurations within resonating communities of brain regions following TMS reveal different scales of processing |
Q34775793 | Repetitive TMS combined with exposure therapy for PTSD: a preliminary study |
Q38801656 | Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis |
Q36731647 | Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
Q35107729 | Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression? |
Q89855171 | Repetitive transcranial magnetic stimulation combined with antidepressants for first episode of major depressive disorder |
Q42636868 | Repetitive transcranial magnetic stimulation for the treatment of depression. |
Q42908717 | Repetitive transcranial magnetic stimulation for the treatment of depression: to stimulate or not to stimulate? |
Q34644102 | Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis |
Q34013833 | Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis |
Q44126383 | Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system |
Q48425044 | Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex improves probabilistic category learning |
Q77946849 | Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial |
Q73200019 | Repetitive transcranial magnetic stimulation: what are the next steps? |
Q34333771 | Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials |
Q34110677 | Seizure models: anticonvulsant effects of ECT and rTMS. |
Q30893498 | Short-term efficacy of repetitive transcranial magnetic stimulation (rTMS) in depression- reanalysis of data from meta-analyses up to 2010. |
Q79867000 | Somatic treatment for depressive illnesses in children and adolescents |
Q39417669 | Strategies for replacing non-invasive brain stimulation sessions: recommendations for designing neurostimulation clinical trials |
Q91938462 | The Insula: A Brain Stimulation Target for the Treatment of Addiction |
Q34593820 | The application of transcranial magnetic stimulation in psychiatry and neurosciences research |
Q45919384 | The author responds:. |
Q44306069 | The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression |
Q40292024 | The future of antidepressant pharmacotherapy |
Q34311455 | Therapeutic application of repetitive transcranial magnetic stimulation: a review |
Q37881968 | Therapeutic options in treatment-resistant depression |
Q58177948 | Traitement des pathologies psychiatriques et stimulation magnétique transcrânienne répétée (rTMS): où en est-on ? |
Q43923765 | Transcranial magnetic stimulation (TMS) effects on testosterone, prolactin, and corticosterone in adult male rats |
Q30500916 | Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression |
Q34442548 | Transcranial magnetic stimulation as a therapeutic tool in psychiatry |
Q34385977 | Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? |
Q34699266 | Transcranial magnetic stimulation for treating depression |
Q48819029 | Transcranial magnetic stimulation in the management of mood disorders |
Q37950262 | Transcranial magnetic stimulation: a new tool in the fight against depression |
Q93143734 | Transcranial magnetic stimulation: an alternative physical treatment in depression |
Q35164252 | Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders |
Q36926952 | Transforming pain medicine: adapting to science and society |
Q27348458 | Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study |
Q64901472 | Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a meta-analysis of randomized controlled trials over 2 decades |
Q43796253 | Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. |
Q42122832 | Utility of repetitive transcranial magnetic stimulation as an augmenting treatment method in treatment-resistant depression. |
Q38727882 | Utility of repetitive transcranial stimulation as an augmenting treatment method in treatment-resistant depression. |
Q92805082 | Ventral tegmental area connections to motor and sensory cortical fields in humans |
Q33519672 | Why do some promising brain-stimulation devices fail the next steps of clinical development? |
Q31121208 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder |
Q51926826 | rCBF changes elicited by rTMS over DLPFC in humans. |
Q35608379 | rTMS as treatment strategy in psychiatric disorders--neurobiological concepts. |
Q57644829 | rTMS for the Treatment of Depression: a Comprehensive Review of Effective Protocols on Right DLPFC |
Search more.